ijms-logo

Journal Browser

Journal Browser

Announcements

4 March 2026
MDPI’s 2025 Best Paper Awards—Award-Winning Papers Announced


MDPI is honored to announce the recipients of the 2025 Best Paper Awards, celebrating exceptional research for its scientific merit and broad impact. After a rigorous evaluation process conducted by Academic Editors, this year’s awards showcase papers that stand out for their innovation, relevance, and high-quality presentation.

Out of a highly competitive pool, 396 winning papers have been recognized for their exceptional contributions. We congratulate these authors for pushing the boundaries of their respective disciplines.

At MDPI, we are dedicated to broadening the reach of innovative science. To learn more about the award-winning papers and explore research projects in your field of study, please visit the following links:

About MDPI Awards:

To reward the global research community and enhance academic dialogue, MDPI journals regularly host award programs across diverse scientific disciplines. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and whose work drives the advancement of their fields.

Explore the Best Paper Awards open for participation, please click here.

 

27 January 2026
Meet Us at the 5th Molecules Medicinal Chemistry Symposium, 14–17 May 2026, Beijing, China


Conference:
5th MMCS: New Trends in Chemical Biology and Drug Discovery
Date: 14–17 May 2026, Beijing Time
Conference website: https://sciforum.net/event/MMCS2026

This conference is organized by the MDPI journal Molecules (ISSN: 1420-3049, IF: 4.6, and CiteScore: 8.6) and will take place in Beijing, China, from 14 to 17 May 2026 (Beijing time).

Conference Chairs:

  • Prof. Dr. Xiaoguang Lei, College of Chemistry and Molecular Engineering, Peking University, China;
  • Prof. Dr. Diego Muñoz-Torrero, Faculty of Pharmacy and Food Sciences, and Institute of Biomedicine (IBUB), University of Barcelona, Spain.

Topics of interest:
S1. Chemical biology for drug discovery;
S2. AI for drug discovery;
S3. New proximity-based drug modalities;
S4. Natural products in drug discovery;
S5. Biocatalysis for natural product and drug synthesis;
S6. Drug discovery targeting GPCRs and ion channels;
S7. DNA-encoded libraries in drug discovery;
S8. Medicinal chemistry tales.

Important dates:
Deadline for abstract submission:
13 March 2026;
Abstract acceptance notification: 27 March 2026;
Early bird registration deadline: 3 April 2026;
Covering author registration deadline: 3 April 2026;
Registration deadline: 14 May 2026.

Guide for authors:
To submit your abstract, please visit the following link: https://sciforum.net/user/submission/create/1319.

To register for the event, please visit the following link: https://sciforum.net/event/MMCS2026?section=#registration.

For more information, you may refer to the following link: https://sciforum.net/event/MMCS2026.

For any inquiries regarding the event, please contact mmcs2026@mdpi.com.

We look forward to seeing you at the 5th MMCS: New Trends in Chemical Biology and Drug Discovery.

22 January 2026
“Do Not Be Afraid of New Things”: Prof. Michele Parrinello on Scientific Curiosity and the Importance of Fundamental Research

In atomic and molecular simulation, researchers have long-needed efficient ways to predict material properties in order to focus on the most promising real laboratory tests instead of redundant work. Addressing this challenge, Prof. Michele Parrinello introduced two transformative methods that have redefined the field: the Car–Parrinello method, which serves as a “virtual lab” for studying reactions and electronic properties, and the Parrinello–Rahman method, a cornerstone for crystal phase transition studies. His work has reshaped the way that we study atomic systems, earning him the status of one of the most cited scholars in his field.

To honor his enduring legacy and continued impact, MDPI has established the Michele Parrinello Award. This award celebrates innovation and recognizes senior scientists who have made outstanding contributions to computational physical sciences, spanning the fields of physics, chemistry, and materials science.

We had the great honor of speaking with Prof. Parrinello in an exclusive interview, where he shared his perspectives on his current research focus, personal scientific experiences, support for basic research, and his advice for global researchers.

Access the full interview to hear his insights in this conversation.

3 April 2026
Colorectal Cancer Awareness Month–March 2026

As part of its ongoing commitment to advancing cancer research and knowledge exchange, MDPI highlights colorectal cancer in the March edition—one of the most prevalent and deadly cancers worldwide. It ranks as the third most diagnosed cancer and the second leading cause of cancer-related deaths globally, with an estimated 1.9 million new cases and over 900,000 deaths each year.

Of growing concern is the steady rise in incidence among individuals under 50, a trend observed over the past two to three decades. This underscores the urgent need to better understand underlying risk factors, strengthen early detection strategies, and develop innovative diagnostic tools.

Through curated research, Special Issues, and expert-led webinars, MDPI journals continue to support collaboration across researchers, clinicians, and policymakers. Such collective efforts are essential to accelerate discoveries and translate them into meaningful action—advancing toward more effective prevention, earlier detection, and improved patient outcomes.

Keynote Speakers
Prof. Dr. Paola Patrignani,
“G. d’Annunzio” University School of Medicine, Italy
Prof. Dr. William Gmeiner,
Wake Forest University, USA

Dr. Eva Martínez-Balibrea,
Catalan Institute of Oncology, Spain

Dr. Zoltán Wiener,
Semmelweis University,
Hungary

Register for this webinar for free here!

Integrative Mechanistic Investigation of the Anticancer Effects of Panax notoginseng in Colorectal Cancer
by Jaemoo Chun, Sarah Shin and Jeeyoun Jung
Molecules 2026, 31(5), 807; https://doi.org/10.3390/molecules31050807  

Integrated Multi-Omics Analysis Identifies Novel Prognostic and Diagnostic Hub Genes in Colorectal Cancer
by Devi Lal and Himani Pandey
Onco 2025, 5(4), 50; https://doi.org/10.3390/onco5040050

A Multimodal MRI-Based Model for Colorectal Liver Metastasis Prediction: Integrating Radiomics, Deep Learning, and Clinical Features with SHAP Interpretation
by Xin Yan, Furui Duan, Lu Chen, Runhong Wang, Kexin Li, Qiao Sun and Kuang Fuby Xin Yan, Furui Duan, Lu Chen, Runhong Wang, Kexin Li, Qiao Sun and Kuang Fu
Curr. Oncol. 2025, 32(8), 431; https://doi.org/10.3390/curroncol32080431  

Exploring Experimental Models of Colorectal Cancer: A Critical Appraisal from 2D Cell Systems to Organoids, Humanized Mouse Avatars, Organ-on-Chip, CRISPR Engineering, and AI-Driven Platforms—Challenges and Opportunities for Translational Precision Oncology”
by Ahad Al-Kabani, Bintul Huda, Jewel Haddad, Maryam Yousuf, Farida Bhurka, Faika Ajaz, Rajashree Patnaik, Shirin Jannati and Yajnavalka Banerjee
Cancers 2025, 17(13), 2163; https://doi.org/10.3390/cancers17132163

The Gut Microbiota and Colorectal Cancer: Understanding the Link and Exploring Therapeutic Interventions
by Imen Zalila-Kolsi, Dhoha Dhieb, Hussam A. Osman and Hadjer Mekideche
Biology 2025, 14(3), 251; https://doi.org/10.3390/biology14030251

A Novel Bacteriophage with the Potential to Inhibit Fusobacterium nucleatum-Induced Proliferation of Colorectal Cancer Cells
by Ho Yin Pekkle Lam, Meng-Jiun Lai, Pin-Chun Wang, Wen-Jui Wu, Li-Kuang Chen, Hsiang-Wei Fan, Chun-Chieh Tseng, Shih-Yi Peng and Kai-Chih Chang
Antibiotics 2025, 14(1), 45; https://doi.org/10.3390/antibiotics14010045

A New Blood-Based Epigenetic Diagnostic Biomarker Test (EpiSwitch®® NST) with High Sensitivity and Positive Predictive Value for Colorectal Cancer and Precancerous Polyps
by Ewan Hunter, Heba Alshaker, Cicely Weston, Mutaz Issa, Shekinah Bautista, Abel Gebregzabhar, Anya Virdi, Ann Dring, Ryan Powell, Jayne Green et al.
Cancers 2025, 17(3), 521; https://doi.org/10.3390/cancers17030521

The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives
by Mitsunobu Takeda, Shoma Yoshida, Takuya Inoue, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe, Takayuki Ogino, Norikatsu Miyoshi, Mamoru Uemura, Hirofumi Yamamoto, Yuichiro Doki and Hidetoshi Eguchi
Cancers 2025, 17(3), 428; https://doi.org/10.3390/cancers17030428

Network Pharmacology and Bioinformatics Study of Six Medicinal Food Homologous Plants Against Colorectal Cancer
by Xinyue Zhao, Jian Xiu, Hengzheng Yang, Weiwei Han and Yue Jin
Int. J. Mol. Sci. 2025, 26(3), 930; https://doi.org/10.3390/ijms26030930

A Review of Potential Agents for Colon Cancer Interception in FAP Patients: Evidence from Preclinical Studies in APCMin/+ Mice
by Karthikkumar Venkatachalam, Krishnendu Goswami, Venkateshwar Madka and Chinthalapally V. Rao
Targets 2025, 3(1), 4; https://doi.org/10.3390/targets3010004

Colorectal Cancer: Epidemiology, Risk Factors, and Prevention
by Gholamreza Roshandel, Fatemeh Ghasemi-Kebria and Reza Malekzadeh
Cancers 2024, 16(8), 1530; https://doi.org/10.3390/cancers16081530

Symptom Burden and Time from Symptom Onset to Cancer Diagnosis in Patients with Early-Onset Colorectal Cancer: A Multicenter Retrospective Analysis
by Victoria A. Baronas, Arif A. Arif, Eric Bhang, Gale K. Ladua, Carl J. Brown, Fergal Donnellan, Sharlene Gill, Heather C. Stuart and Jonathan M. Loree
Curr. Oncol. 2024, 31(4), 2133-2144; https://doi.org/10.3390/curroncol31040158

 

Recent Advances in Surgical Strategies for Managing Metastatic Colorectal Cancer
Guest Editors: Dr. Fabrizio D'Acapito and Dr. Marco Vaira
Deadline for manuscript submissions: 15 June 2026

Novel Strategies in the Prevention/Treatment of Colorectal Cancer: 2nd Edition
Guest Editor: Prof. Dr. William H. Gmeiner
Deadline for manuscript submissions: 20 June 2026

Molecular Mechanisms and Therapeutic Strategies of Colorectal Cancer
Guest Editor: Dr. Daniel Gabriel Pons
Deadline for manuscript submissions: 20 September 2026

Gut Microbiota and Inflammation in Colorectal Tumor Development and Progression
Guest Editors: Prof. Dr. Giovanni Monteleone and Dr. Irene Marafini
Deadline for manuscript submissions: 30 September 2026

       

2 April 2026
2026 Tu Youyou Award—Open for Nominations


We are delighted to announce that nominations are now open for the 2026 Tu Youyou Award. Named after Nobel Laureate Tu Youyou, whose discovery of artemisinin has saved millions of lives, this award recognizes researchers whose work advances the fields of natural products chemistry and medicinal chemistry, while also contributing to human health.

Prize

– CHF 100,000;
– A medal;
– A certificate.

The monetary prize will be shared equally should there be multiple recipients.

Who May Be Nominated?

– Scientists with outstanding achievements and contributions in the fields of natural products chemistry and medicinal chemistry.

Nominees must be individuals; team or group nominations are not permitted. Nominations are valid only for the current award cycle.

Who May Submit a Nomination?

– The director of the nominee’s host research institution or recognized scientists within the field.

Self-nominations will not be considered.

Nomination Materials

– A biographical sketch;
– A detailed description of the nominee’s contributions;
– 5–10 representative academic publications;
– A list of academic honors, awards, and funded projects;
– A nomination letter signed by two nominators.

How to Submit?

Submit nominations online via the following link: https://tuyouyouprize.org/nomination

Important Dates

– Nomination Deadline: 31 October 2026
– Winner Announcement: March 2027

For further information, please visit the Tu Youyou Award website (https://tuyouyouprize.org/). For any inquiries, please contact the Tu Youyou Award Team at tuyouyouaward@mdpi.com.

1 April 2026
Meet Us at the 9th China–Europe Symposium on Biomaterials in Regenerative Medicine in 2026, 10–13 May 2026, Beijing, China


Conference: The 9th China–Europe Symposium on Biomaterials in Regenerative Medicine
Organization: Chinese Society for Biomaterials
Date: 10–13 May 2026
Location: Beijing, China

The China–Europe Symposium on Biomaterials in Regenerative Medicine (CESB) is a premier international conference jointly organized by the Chinese Society for Biomaterials (CSBM) and the European Society for Biomaterials (ESB). Initiated in 2006 by Prof. Xingdong Zhang (then President of the Chinese Committee for Biomaterials, the predecessor to the CSBM) and Prof. Luigi Ambrosio (then President of the ESB), CESB has been held biennially, alternating between China and Europe, to foster cross-continental collaboration and knowledge exchange in the field of biomaterials and regenerative medicine.

CESB brings together leading researchers, clinicians, and industry experts from China and Europe to discuss cutting-edge advancements, innovative technologies, and clinical applications in biomaterials. The symposium covers a wide range of topics, including tissue engineering, nanotechnology, immunomodulation, advanced biomaterials, and translational medicine.

As a key platform for sustained Sino-European scientific collaboration, CESB continues to drive global progress in biomaterials research and its clinical implementation, contributing to the future of regenerative medicine worldwide.

The following open access journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth. Our delegates look forward to meeting you in person.

For more information about the conference, please visit the following link: https://cesb2026.csbm.org.cn/index.php/index/index/index.html.

31 March 2026
MDPI INSIGHTS: The CEO’s Letter #33 - 2025 Annual Report, Preprints.org, IWD, Recapping Viruses 2026 & Romania Salon

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Scaling Open Access with Integrity: MDPI Annual Report 2025

I am pleased to share the release of MDPI’s 2025 Annual Report, reflecting our continued progress as one of the world’s leading open access publishers. The report highlights not only our growth, but also the continued evolution of our publishing model and our commitment to quality, transparency, and collaboration.

You can explore the full report here: https://mdpi-res.com/data/mdpi_annual_report_2025_0401.pdf?1775045421

Or visit the interactive page: https://www.mdpi.com/annual-report-2025/

A Year of Growth and Responsibility

2025 was a year of significant growth for MDPI. We received over 669,000 manuscript submissions, the highest in our history, while maintaining a rejection rate above 60%, reinforcing our commitment to both scale and quality.

We published 261,576 peer-reviewed open access articles across a portfolio of 500 journals, supported by a global community of more than 68,000 Editorial Board Members and 209,000 reviewers.

Scaling with Integrity

Growth alone is not the objective; how we grow matters.

Our 2025 Annual Report, Scaling Open Access with Integrity, reflects our continued focus on building the systems and processes that support reliable and trustworthy publishing. As submission volumes increase globally, so too does the importance of robust editorial workflows, research integrity frameworks, and the infrastructure required to support them.

In 2025, we continued to invest in:

  • Research integrity and quality assurance processes
  • Editorial support and reviewer engagement
  • Transparency across the publishing workflow

These efforts ensure that scale does not come at the expense of rigor, but rather reinforces it.

Validation Through Indexing and Visibility

As MDPI continues to grow, validation of quality remains essential.

In 2025, the number of MDPI journals indexed in the Web of Science Core Collection increased from 298 to 329, while Scopus coverage reached 355 journals, including 45 new acceptances. Coverage in major biomedical databases (PMC/Medline/PubMed) expanded to 95 journals, and indexing in Ei Compendex increased significantly.

These milestones reflect the strength of our editorial processes and the trust placed in our journals by independent indexing bodies.

Importantly:

  • 96% of all MDPI articles are indexed in Web of Science databases
  • More than 1.75 million articles are indexed, with an average of 13 citations per article

Recognition through Journal Citation Reports also continues to grow:

  • 298 journals received Impact Factors
  • 65% ranked in the top half of their categories
  • 61 journals achieved top-quartile positions

These developments demonstrate that growth and quality are advancing together, supported by strong editorial oversight and consistent performance across our journal portfolio.

Strengthening Partnerships and Community

Open access is a collaborative endeavor.

In 2025, we expanded our institutional partnerships to more than 1,000 IOAP agreements, helping simplify publishing for researchers and institutions worldwide.

We also hosted 60 in-person conferences and virtual events, bringing together more than 28,000 participants to exchange ideas, share research, and strengthen connections across the global scientific community.

At the heart of everything we do is this community of authors, editors, reviewers, and partners who make open science possible.

Looking Ahead

Open access continues to move toward becoming the standard model for sharing research globally. With that growth comes increased responsibility.

Our focus moving forward is to continue building a publishing ecosystem that is:

  • Collaborative, to serve the research community
  • Rigorous, to ensure quality
  • Transparent, to support trust
  • Scalable, to meet global demand

We believe that open access, when combined with strong editorial standards and integrity, is the most effective way to accelerate scientific progress.

Thank you to all the scholarly community who collaborated with us and our MDPI staff for your continued dedication and contributions in making 2025 a successful year.

Impactful Research

Celebrating Ten Years of Preprints.org: Accelerating Open Research

In 2026, MDPI’s preprints server Preprints.org marked its 10th anniversary as a platform dedicated to accelerating the dissemination of research. Since its launch, Preprints.org has grown into a global platform that hosts more than 120,000 preprints contributed by hundreds of thousands of researchers worldwide, generating tens of millions of views and downloads and demonstrating the value of sharing research openly and rapidly.

At MDPI, we are proud to celebrate ten years of Preprints.org supporting the mission of open science. Over the past decade, we have seen how early sharing of research can accelerate collaboration and help ideas move more quickly from discovery to impact.

The Evolution of Preprints

While Preprints.org launched in 2016, the idea behind it has deeper roots. The concept of rapid research dissemination has existed for decades, with early preprint servers showing how open sharing can accelerate scientific progress.

Over the past decade, preprints have become an increasingly important part of scholarly communication. Researchers across disciplines are looking at faster ways to share their discoveries, exchange ideas, and receive feedback from the global scientific community.

Preprints in a Growing Research Ecosystem

The global preprint landscape has expanded significantly over the past decade, with multiple platforms serving different research communities. The figure below (sourced from James Butcher newsletter), based on data from Dimensions (Digital Science), shows the growth of preprint outputs across several major platforms over time.

Among these platforms, arXiv (the pioneering preprint server) has experienced great growth in recent years. At the same time, other platforms have continued to expand their reach across disciplines, capturing increasing global interest in early research sharing.

Preprints.org contributes to this evolving ecosystem by providing a multidisciplinary platform that works in synergy with academic journals, helping researchers bridge the gap between rapid dissemination and the formal publication process.

Celebrating the First Decade

To commemorate this milestone, Preprints.org launched a 10th Anniversary celebration hub highlighting the impact of preprints and the researchers who contribute to them.

One of the central initiatives is the Popular Preprints of the Decade Award, recognizing influential preprints published between 2016 and 2026 across multiple research fields. Through community voting, the award will recognize research that has generated high engagement and visibility within the global research community.

Looking Ahead: The Next Decade of Preprints

As research communication continues to evolve, preprints will continue to play an important role in enabling faster collaboration, improving transparency, and expanding access to knowledge. The next decade may bring further integration between preprint platforms and journals, new tools for discovery and evaluation, and greater global participation in open science.

At MDPI, we remain committed to supporting researchers through platforms that encourage the open exchange of ideas. The success of Preprints.org over the past ten years reflects the engagement and trust of the global research community – authors, readers, reviewers, and collaborators who believe in the value of sharing knowledge openly.

Congratulations to everyone involved in the development and growth of Preprints.org over the past decade!

Inside MDPI

Beyond International Women’s Day: Supporting Women in Research

International Women’s Day (IWD) offers an opportunity to recognize the achievements of women around the world and reflect on how we can continue building a more inclusive future. In research and academia, this conversation carries particular importance, as scientific progress depends on diverse perspectives, and supporting women in science is essential to strengthening the global research ecosystem.

For MDPI, IWD is an opportunity to celebrate the achievements of women in research and highlight the initiatives, conversations, and collaborations that help support researchers across disciplines and career stages.

Highlighting Women in Science Across MDPI

This year, MDPI marked International Women’s Day with a global campaign highlighting research, awards, and perspectives that support women in science. Throughout the week, our teams shared content across MDPI’s social media channels sharing the work of women researchers and encouraging engagement across the academic community.

As part of this initiative, MDPI published several blog articles exploring important themes related to gender equity in research. One article, Give Support, Gain Progress: Retaining Women in Science, discusses the importance of mentorship, institutional support, and inclusive research environments in helping women build sustainable scientific careers.

Another featured article, Bridging the Gap in Women’s Health Research, highlights the ongoing need to address disparities in health research and ensure that women’s health receives the scientific attention and investment it deserves.

These topics capture the notion that supporting women in science benefits not only individual researchers but the entire scientific community. When researchers from diverse backgrounds can contribute their perspectives and ideas, the scope and impact of scientific discovery expand.

Creating Spaces for Dialogue

Beyond online content, MDPI is also supporting conversations about women in research through community engagement.

On 10 March, MDPI UK hosted the “Women in Research” event, bringing together researchers and professionals to share experiences and discuss the opportunities and challenges women face throughout their scientific careers. Events like these are an opportunity for open dialogue, mentorship, and networking to create more inclusive research communities.

Looking Beyond a Single Day

While IWD is an important moment of recognition, progress requires ongoing effort.

Supporting women in research involves many forms of engagement: from mentorship and collaboration to creating inclusive environments in which diverse voices are heard and valued. Publishers, institutions, and researchers all play a role in building this ecosystem.

At MDPI, we remain committed to supporting the global research community and to promoting open access publishing as a foundation for accessible and inclusive knowledge-sharing.

As we reflect on IWD this year, we recognize the many women who contribute to research as authors, reviewers, editors, mentors, and educators; we also recognize the impact they continue to have on the advancement of science. The influence of women in research extends far beyond a single day of recognition, reminding us that supporting them is a commitment that continues throughout the year.

Coming Together for Science

Highlights from Viruses 2026 – New Horizons in Virology (11–13 March)

Through 11–13 March, we successfully delivered the Viruses 2026 – New Horizons in Virology MDPI conference in Barcelona, bringing together an international community of researchers, editors, and partners dedicated to advancing the field of virology.

Conference Highlights

Viruses 2026 in numbers:

  • 198 total registrations, with 171 attendees on site
  • 233 submissions, with 122 accepted
  • 42 short talks, 9 flash talks, and 80 posters
  • 13 invited speakers and 1 keynote speaker

The strong level of participation and quality of submissions once again demonstrate the relevance of the Viruses community.

A standout moment was the keynote lecture by Dr. Ho, which also attracted an NBC documentary film crew, highlighting the broader impact of the research being presented.

Scientific Programme

The conference programme covered areas across modern virology, including viral replication, pathogenesis, immunology, and public health. Sessions explored topics on antiviral therapeutics and vaccines, innate immunity, virus–host interactions, and the structure and mechanisms of virus replication.

Together, these discussions highlighted both the fundamental biology of viruses and the translational challenges of addressing emerging infectious diseases, reflecting the breadth and continued importance of virology research in a global context. The programme also included a sponsored workshop on research data management in virology, further emphasizing the importance of data practices in advancing the field.

Thank You

Feedback from participants has been very positive, and I would like to thank the Conference team for the organization and delivery of this year’s event.

Thank you to our Viruses journal team and all colleagues involved behind the scenes in supporting the delivery of the event. As noted by Dr. Eric Freed (EiC of Viruses), the success of this edition gives us strong momentum as we look ahead to the next conference in 2028, with opportunities to further expand participation and engagement.

Closing Thoughts

Recap from MDPI Romania Salon in Cluj-Napoca (24 March)

On 24 March, we had the opportunity to meet with members of the Romanian research community in Cluj-Napoca at our MDPI Romania Salon. The event was a space for presentations, open discussion, and the exchange of perspectives on publishing and the research landscape in Romania.

We welcomed 39 participants, including 27 researchers from institutions across Romania, representing cities such as Cluj-Napoca, Timișoara, and Reșița. Among them were Editorial Board Members, Associate Editors, and Guest Editors, all of whom play an important role in collaborating with MDPI and shaping the quality and direction of academic publishing.

A Shared Commitment to Research Excellence

These events reflect MDPI’s commitment to connecting with and supporting researchers by means of transparency, dialogue, and collaboration. During the day, MDPI colleagues shared a series of presentations covering different parts of our publishing ecosystem:

  • MDPI’s presence in Romania – Anamaria Vartolomei (Journal Relationship Specialist (JRS), Section Managing Editor (ME))
  • MDPI’s performance, growth, and impact in Romania – Stefan Tochev (CEO)
  • Academic services, initiatives, and projects supporting researchers – Ioana Preda (JRS, Section ME)
  • Best practices and standards in publication ethics – Lavinia Rogojina (Research Integrity Manager)
  • Panel session on ethics, AI, and peer review – Lavinia Rogojina, Ioana Preda, Doris Larisa Albu (JRS, Section ME), Cristina Georgiana Spelmezan (JRS, Section ME)
  • Closing remarks – Lavinia Dumitrela Cozma (Operations Manager, Section ME)

Feedback from participants was very positive, particularly regarding the quality of discussions, the relevance of the topics, and the opportunity to engage directly with MDPI colleagues. What stood out most was the openness of the discussion. These events are important not only for the purposes of presenting what we do, but also as an opportunity to listen, understand concerns, and continue to build alignment with the research community.

Romania and the Growth of Open Access Publishing

The Romanian research landscape continues to show growth in open access (OA) publishing.

In 2025:

  • 72% of all publications in Romania were published as OA
  • Of these, 74% were Gold Open Access

Over the past five years, Romania has produced more than 109,000 publications, with approximately 71% available openly, highlighting a sustained shift toward accessibility and knowledge-sharing.

Within this landscape, MDPI continues to play a significant role:

  • MDPI is the leading OA publisher in Romania, contributing 42% of all OA publications in 2025
  • More than 37,000 articles have been published with MDPI by Romanian institutions since 1996
  • This figure includes over 7,500 publications in 2025 alone
  • More than 400 Editorial Board Members from Romania collaborate with MDPI across disciplines

These trends show the growth of OA and the strength of collaboration between MDPI and the Romanian research community.

Looking Ahead

As academic publishing continues to evolve, maintaining open and transparent communication with researchers is essential. Events such as our Salons and Summits provide great opportunities to exchange perspectives and to build trust and collaboration.

Thank you to all participants who joined us in Cluj, and to our teams in Romania for delivering a successful event. A special thank-you to Alina-Florina Agafitei (Marketing Specialist) for her care and attention to detail in delivering the Salon.

Stefan Tochev
Chief Executive Officer
MDPI AG

25 March 2026
Acknowledging the Contributions of Our Reviewers in 2025


As a pioneer in open access publishing, MDPI maintains rigorous publication standards. This mission relies on the dedication and expertise of our reviewers, who invest their time and knowledge to ensure the quality and integrity of the research we publish.

In 2025, over 209,000 reviewers contributed to the peer-review process at MDPI, providing more than 1.3 million review reports for our journals. To express our gratitude, MDPI’s Reviewer Recognition Program highlights reviewers across over 400 journals, featuring those who have assessed at least one manuscript and agreed to be acknowledged.

In addition, MDPI has identified its Top 1000 Reviewers of 2024 to recognize those whose expertise, dedication, and thoughtful evaluations were particularly outstanding.

Many journals have also established Outstanding Reviewer Awards to honor our reviewers’ commitment to publication excellence. Together with the Exceptional Reviewer List, we showcase the importance of reviewers’ work and their time and dedication.

These initiatives serve to express our deepest appreciation and gratitude towards the whole reviewer community. In recognition of their contributions, we also welcome new researchers to join this community. If you would like to contribute to open access publishing, learn more about the reviewers’ benefits and sign up to join us.

24 March 2026
World Tuberculosis Day 2026—“Yes! We Can End TB: Led by Countries, Powered by People.”, 24 March 2026


Tuberculosis is a disease that is both preventable and treatable, significantly affecting people’s health and quality of life worldwide. Every year, we commemorate World Tuberculosis Day to raise public awareness of the devastating health, social, and economic consequences of tuberculosis (TB) and to intensify efforts to end the global TB epidemic. The date signifies the day in 1882 when Dr. Robert Koch announced his discovery of the bacterium responsible for TB, which paved the way for diagnosing and curing this disease.

The theme of World TB Day 2026, “Yes! We can End TB! Led by Countries, Powered by People”, is a bold call to action and a message of hope, affirming that it is possible to get back on track and turn the tide on the TB epidemic, even in a challenging global environment. With decisive country leadership, increased domestic and international investment, rapid uptake of new WHO recommendations and innovations, accelerated action, and strong multisectoral collaboration, ending TB is not just aspirational—it is achievable.

We hope that established journals in the fields of biology, life sciences, medicine, and pharmacology at MDPI will continue to serve as a communication platform for innovative ideas regarding prevention and treatment.

 

 

 

 Trends in Tuberculosis Incidence and Mortality in South Africa and Bulgaria (2000–2023): The Impact of Income, Poverty, Unemployment, and Universal Health Coverage
by Siyabonga Kave, Joana Simeonova, Antoniya Yanakieva, Alexandrina Vodenitcharova, Denisha Govender, Yandisa Sikweyiya and Nelisiwe Khuzwayo
Epidemiologia 2026, 7(2), 39; https://doi.org/10.3390/epidemiologia7020039

Humoral Immune Activation Against Mycobacterium avium subsp. paratuberculosis Through Oral Immunization with Engineered Salmonella
by Azar Motamedi Boroojeni, Nikoo Veiskarami, Elena Rita Simula, Leonardo Antonio Sechi and Abdollah Derakhshandeh
Bacteria 2025, 4(3), 47; https://doi.org/10.3390/bacteria4030047

History of Pulmonary Tuberculosis Accelerates Early Onset and Severity of COPD: Evidence from a Multicenter Study in Romania
by Ramona Cioboata, Silviu Gabriel Vlasceanu, Denisa Maria Mitroi, Ovidiu Mircea Zlatian, Mara Amalia Balteanu, Gabriela Marina Andrei, Viorel Biciusca and Mihai Olteanu
J. Clin. Med. 2025, 14(17), 5980; https://doi.org/10.3390/jcm14175980

Integration of AI and ML in Tuberculosis (TB) Management: From Diagnosis to Drug Discovery
by Sameeullah Memon, Shabana Bibi and Guozhong He
Diseases 2025, 13(6), 184; https://doi.org/10.3390/diseases13060184

Three-Dimensional-Printed Isoniazid Chewable Gels for On-Demand Latent Tuberculosis Treatment in Children
by Amanda de O. E. Moreira, Lêda Maria S. Azevedo Neta, Márcia Pietroluongo, Ana Paula dos S. Matos, Beatriz B. Correa, Beatriz H. Ortiz, André da S. Guimarães, Marcio Nele, Carollyne M. Santos, Ana Elizabeth C. Fai et al.
Pharmaceutics 2025, 17(5), 658; https://doi.org/10.3390/pharmaceutics17050658

Prevalence and Associated Factors of Latent Tuberculosis Infection Among Healthcare Workers in a Mexican Tertiary Care Hospital
by José Ángel Hernández-Mariano, Mónica Alethia Cureño-Díaz, Verónica Fernández-Sánchez, Estibeyesbo Said Plascencia-Nieto, Dulce Milagros Razo-Blanco-Hernández, Claudia Vázquez-Zamora, Víctor Hugo Gutiérrez-Muñoz, Beatriz Leal-Escobar, Erika Gómez-Zamora and Yanelly Estrella Morales-Vargas
Diseases 2025, 13(6), 173; https://doi.org/10.3390/diseases13060173

The Complex Relationship Between Tuberculosis and Hyperglycemia
by Michelle Byers and Elizabeth Guy
Diagnostics 2024, 14(22), 2539; https://doi.org/10.3390/diagnostics14222539

The Role of mTOR in Mycobacterium tuberculosis Infection
by Ami Patel, Lannhi Nguyen, Christina Shea, Sunjum Singh and Vishwanath Venketaraman
Biomedicines 2024, 12(10), 2238; https://doi.org/10.3390/biomedicines12102238

Tuberculosis-Induced Immune-Mediated Necrotizing Myopathy: A Challenging Case Scenario in a Non-Endemic Country
by Agnese Colpani, Davide Astorri, Andrea De Vito, Giordano Madeddu, Sandro Panese and Nicholas Geremia
Reports 2024, 7(4), 82; https://doi.org/10.3390/reports7040082

Adherence to Short-Duration Treatment (3HP) for Latent Tuberculosis among International Migrants in Manaus, Amazonas: Evaluation of the Efficacy of Different Treatment Modalities
by Yan Mathias Alves, Thaís Zamboni Berra, Sonia Vivian de Jezus, Vânia Maria Silva Araújo, Jair dos Santos Pinheiro, Lara Bezerra de Oliveira de Assis, Marvis Canelonez, Daniel Souza Sacramento, Freddy Perez, Ethel Leonor Noia Maciel et al.
Microorganisms 2024, 12(8), 1629; https://doi.org/10.3390/microorganisms12081629

A Multidisciplinary Approach to the Management of Eales Disease: A Case Report and Review of the Literature
by Maria Filoftea Mercut, Oana Maria Ică, Cornelia Andreea Tănasie, Răzvan Mercuț, Carmen Luminița Mocanu, Andreea Mihaela Nicolcescu and Ciprian Danielescu
J. Pers. Med. 2024, 14(3), 235; https://doi.org/10.3390/jpm14030235

Mycobacterium tuberculosis Deficient in PdtaS Cytosolic Histidine Kinase Displays Attenuated Growth and Affords Protective Efficacy against Aerosol M. tuberculosis Infection in Mice
by Kelly A. Prendergast, Gayathri Nagalingam, Nicholas P. West and James A. Triccas
Vaccines 2024, 12(1), 50; https://doi.org/10.3390/vaccines12010050

Novel Therapeutic Agents and Innovative Delivery Systems Against Infectious Diseases
Guest Editor: Dr. Sara Consalvi
Submission deadline: 30 June 2026

Genomic Epidemiology & Drug Resistance in Mycobacterium tuberculosis
Guest Editors: Dr. Benson Kidenya and Dr. Gerald Mboowa
Submission deadline: 30 June 2026

Mycobacterial Infections and Human Disease: Emerging Mechanisms and Therapeutic Strategies/Boundaries
Guest Editors: Dr. Sameer Tiwari, Dr. Ashutosh Tripathi and Prof. Dr. Shahid Umar
Submission deadline: 1 August 2026

Recent Advances in Molecular and Cellular Approaches to Tuberculosis Pathogenesis, Treatment and Prevention
Guest Editor: Dr. Selvakumar Subbian
Submission deadline: 20 August 2026

Personalized Medicine in Epidemiology and Infectious Diseases
Guest Editors: Prof. Dr. Takalani Grace Tshitangano and Prof. Dr. Daniel Ter Goon
Submission deadline: 20 September 2026

Biomolecules in Mycobacterial Pathogenesis, Host–Pathogen Interactions, and Antimicrobial and Therapeutic Approaches
Guest Editor: Dr. Cinzia Marianelli
Submission deadline: 31 December 2026

24 March 2026
Meet Us at the Society for Research on Biological Rhythm 2026 Biennial Meeting, 9–13 May 2026, Amelia Island, Florida, USA


Conference:
The Society for Research on Biological Rhythm 2026 Biennial Meeting
Date: 9 May 2026–13 May 2026
Location: Amelia Island, Florida, USA

We are pleased to announce that MDPI will be participating in the 2026 Biennial Meeting of the Society for Research on Biological Rhythms (SRBR), taking place from May 9–13, 2026, at the Omni Amelia Island Resort & Spa, Florida, USA.

As one of the world’s leading international forums for the exchange of cutting-edge scientific information, the SRBR Biennial Meeting brings together researchers from all areas of chronobiology to share the latest advances in biological rhythms research.

The SRBR Biennial Meeting provides an opportunity to:

  • Attend an outstanding scientific program;
  • Learn about the most recent and often advances in biological rhythms. This year’s meeting will feature Circadian Medicine that will mark its emergence as a new important area of chronobiology;
  • Meet and interact with internationally distinguished researchers and scientists.

Visit our booth to discover MDPI’s latest publications, Special Issues, and open access initiatives in chronobiology, circadian medicine, and related fields. Our editors will be on hand to discuss your research and answer any questions about publishing with MDPI.

The following open access journals will be represented at the conference:

If you will be attending this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit https://srbr.org/2026-biennial-meeting/#.

Back to TopTop